dichloroplatinum;bis(3,5-dimethylpyrazol-1-ide);5-isoquinolin-1-yl-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;bis(2-(5-methyl-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl)pyridine);bis(2-(5-methylpyrazol-2-id-3-yl)pyrazine);bis(2-(5-methylpyrazol-2-id-3-yl)pyridine);2-(3-phenylpyrazol-1-id-5-yl)pyridine;platinum;hexakis(platinum(2+));bis(pyrazol-1-ide);pyridine-2-carboxylic acid;bis(2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine)

C124H109Cl2F6N43O2Pt8-2 — CID 159858727

IUPACdichloroplatinum;bis(3,5-dimethylpyrazol-1-ide);5-isoquinolin-1-yl-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;bis(2-(5-methyl-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl)pyridine);bis(2-(5-methylpyrazol-2-id-3-yl)pyrazine);bis(2-(5-methylpyrazol-2-id-3-yl)pyridine);2-(3-phenylpyrazol-1-id-5-yl)pyridine;platinum;hexakis(platinum(2+));bis(pyrazol-1-ide);pyridine-2-carboxylic acid;bis(2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine)
SMILESCC12CCC(c3c1n[n-]c3-c1nccc3ccccc13)C2(C)C.Cc1cc(-c2ccccn2)[n-]n1.Cc1cc(-c2ccccn2)[n-]n1.Cc1cc(-c2cnccn2)[n-]n1.Cc1cc(-c2cnccn2)[n-]n1.Cc1cc(C)[n-]n1.Cc1cc(C)[n-]n1.Cc1n[n-]c(-c2ccccn2)n1.Cc1n[n-]c(-c2ccccn2)n1.Cl[Pt]Cl.FC(F)(F)c1cc(-c2ccccn2)[n-]n1.FC(F)(F)c1cc(-c2ccccn2)[n-]n1.O=C(O)c1ccccn1.[Pt+2].[Pt+2].[Pt+2].[Pt+2].[Pt+2].[Pt+2].[Pt].c1ccc(-c2cc(-c3ccccn3)[n-]n2)cc1.c1cn[n-]c1.c1cn[n-]c1
InChIInChI=1S/C20H20N3.C14H10N3.2C9H5F3N3.2C9H8N3.4C8H7N4.C6H5NO2.2C5H7N2.2C3H3N2.2ClH.8Pt/c1-19(2)14-8-10-20(19,3)18-15(14)17(22-23-18)16-13-7-5-4-6-12(13)9-11-21-16;1-2-6-11(7-3-1)13-10-14(17-16-13)12-8-4-5-9-15-12;2*10-9(11,12)8-5-7(14-15-8)6-3-1-2-4-13-6;2*1-7-6-9(12-11-7)8-4-2-3-5-10-8;2*1-6-4-7(12-11-6)8-5-9-2-3-10-8;2*1-6-10-8(12-11-6)7-4-2-3-5-9-7;8-6(9)5-3-1-2-4-7-5;2*1-4-3-5(2)7-6-4;2*1-2-4-5-3-1;;;;;;;;;;/h4-7,9,11,14H,8,10H2,1-3H3;1-10H;2*1-5H;2*2-6H,1H3;4*2-5H,1H3;1-4H,(H,8,9);2*3H,1-2H3;2*1-3H;2*1H;;;;;;;;/q10*-1;;4*-1;;;;7*+2/p-2
InChIKeyINLHRTKWDQPGNR-UHFFFAOYSA-L
MW3979.05 g/mol
LogP21.00
Rot. Bonds12

About dichloroplatinum;bis(3,5-dimethylpyrazol-1-ide);5-isoquinolin-1-yl-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;bis(2-(5-methyl-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl)pyridine);bis(2-(5-methylpyrazol-2-id-3-yl)pyrazine);bis(2-(5-methylpyrazol-2-id-3-yl)pyridine);2-(3-phenylpyrazol-1-id-5-yl)pyridine;platinum;hexakis(platinum(2+));bis(pyrazol-1-ide);pyridine-2-carboxylic acid;bis(2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine)

dichloroplatinum;bis(3,5-dimethylpyrazol-1-ide);5-isoquinolin-1-yl-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;bis(2-(5-methyl-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl)pyridine);bis(2-(5-methylpyrazol-2-id-3-yl)pyrazine);bis(2-(5-methylpyrazol-2-id-3-yl)pyridine);2-(3-phenylpyrazol-1-id-5-yl)pyridine;platinum;hexakis(platinum(2+));bis(pyrazol-1-ide);pyridine-2-carboxylic acid;bis(2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine) (PubChem CID 159858727) has the molecular formula C124H109Cl2F6N43O2Pt8-2 and a molecular weight of 3979.05 g/mol. Its IUPAC name is dichloroplatinum;bis(3,5-dimethylpyrazol-1-ide);5-isoquinolin-1-yl-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;bis(2-(5-methyl-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl)pyridine);bis(2-(5-methylpyrazol-2-id-3-yl)pyrazine);bis(2-(5-methylpyrazol-2-id-3-yl)pyridine);2-(3-phenylpyrazol-1-id-5-yl)pyridine;platinum;hexakis(platinum(2+));bis(pyrazol-1-ide);pyridine-2-carboxylic acid;bis(2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine).

Molecular Properties

Compound Namedichloroplatinum;bis(3,5-dimethylpyrazol-1-ide);5-isoquinolin-1-yl-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;bis(2-(5-methyl-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl)pyridine);bis(2-(5-methylpyrazol-2-id-3-yl)pyrazine);bis(2-(5-methylpyrazol-2-id-3-yl)pyridine);2-(3-phenylpyrazol-1-id-5-yl)pyridine;platinum;hexakis(platinum(2+));bis(pyrazol-1-ide);pyridine-2-carboxylic acid;bis(2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine)
PubChem CID159858727
Molecular FormulaC124H109Cl2F6N43O2Pt8-2
Molecular Weight3979.05 g/mol
Exact Mass3975.62
IUPAC Namedichloroplatinum;bis(3,5-dimethylpyrazol-1-ide);5-isoquinolin-1-yl-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;bis(2-(5-methyl-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl)pyridine);bis(2-(5-methylpyrazol-2-id-3-yl)pyrazine);bis(2-(5-methylpyrazol-2-id-3-yl)pyridine);2-(3-phenylpyrazol-1-id-5-yl)pyridine;platinum;hexakis(platinum(2+));bis(pyrazol-1-ide);pyridine-2-carboxylic acid;bis(2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine)
SMILESCC12CCC(c3c1n[n-]c3-c1nccc3ccccc13)C2(C)C.Cc1cc(-c2ccccn2)[n-]n1.Cc1cc(-c2ccccn2)[n-]n1.Cc1cc(-c2cnccn2)[n-]n1.Cc1cc(-c2cnccn2)[n-]n1.Cc1cc(C)[n-]n1.Cc1cc(C)[n-]n1.Cc1n[n-]c(-c2ccccn2)n1.Cc1n[n-]c(-c2ccccn2)n1.Cl[Pt]Cl.FC(F)(F)c1cc(-c2ccccn2)[n-]n1.FC(F)(F)c1cc(-c2ccccn2)[n-]n1.O=C(O)c1ccccn1.[Pt+2].[Pt+2].[Pt+2].[Pt+2].[Pt+2].[Pt+2].[Pt].c1ccc(-c2cc(-c3ccccn3)[n-]n2)cc1.c1cn[n-]c1.c1cn[n-]c1
InChIInChI=1S/C20H20N3.C14H10N3.2C9H5F3N3.2C9H8N3.4C8H7N4.C6H5NO2.2C5H7N2.2C3H3N2.2ClH.8Pt/c1-19(2)14-8-10-20(19,3)18-15(14)17(22-23-18)16-13-7-5-4-6-12(13)9-11-21-16;1-2-6-11(7-3-1)13-10-14(17-16-13)12-8-4-5-9-15-12;2*10-9(11,12)8-5-7(14-15-8)6-3-1-2-4-13-6;2*1-7-6-9(12-11-7)8-4-2-3-5-10-8;2*1-6-4-7(12-11-6)8-5-9-2-3-10-8;2*1-6-10-8(12-11-6)7-4-2-3-5-9-7;8-6(9)5-3-1-2-4-7-5;2*1-4-3-5(2)7-6-4;2*1-2-4-5-3-1;;;;;;;;;;/h4-7,9,11,14H,8,10H2,1-3H3;1-10H;2*1-5H;2*2-6H,1H3;4*2-5H,1H3;1-4H,(H,8,9);2*3H,1-2H3;2*1-3H;2*1H;;;;;;;;/q10*-1;;4*-1;;;;7*+2/p-2
InChIKeyINLHRTKWDQPGNR-UHFFFAOYSA-L
XLogP21.00
TPSA608.51 Ų
H-Bond Donors1
H-Bond Acceptors30
Rotatable Bonds12
Heavy Atoms185
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5003979.05
LogP ≤ 521.00
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1030

Analyze dichloroplatinum;bis(3,5-dimethylpyrazol-1-ide);5-isoquinolin-1-yl-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;bis(2-(5-methyl-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl)pyridine);bis(2-(5-methylpyrazol-2-id-3-yl)pyrazine);bis(2-(5-methylpyrazol-2-id-3-yl)pyridine);2-(3-phenylpyrazol-1-id-5-yl)pyridine;platinum;hexakis(platinum(2+));bis(pyrazol-1-ide);pyridine-2-carboxylic acid;bis(2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of dichloroplatinum;bis(3,5-dimethylpyrazol-1-ide);5-isoquinolin-1-yl-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;bis(2-(5-methyl-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl)pyridine);bis(2-(5-methylpyrazol-2-id-3-yl)pyrazine);bis(2-(5-methylpyrazol-2-id-3-yl)pyridine);2-(3-phenylpyrazol-1-id-5-yl)pyridine;platinum;hexakis(platinum(2+));bis(pyrazol-1-ide);pyridine-2-carboxylic acid;bis(2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine)?
The IUPAC name of dichloroplatinum;bis(3,5-dimethylpyrazol-1-ide);5-isoquinolin-1-yl-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;bis(2-(5-methyl-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl)pyridine);bis(2-(5-methylpyrazol-2-id-3-yl)pyrazine);bis(2-(5-methylpyrazol-2-id-3-yl)pyridine);2-(3-phenylpyrazol-1-id-5-yl)pyridine;platinum;hexakis(platinum(2+));bis(pyrazol-1-ide);pyridine-2-carboxylic acid;bis(2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine) (CID 159858727) is dichloroplatinum;bis(3,5-dimethylpyrazol-1-ide);5-isoquinolin-1-yl-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;bis(2-(5-methyl-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl)pyridine);bis(2-(5-methylpyrazol-2-id-3-yl)pyrazine);bis(2-(5-methylpyrazol-2-id-3-yl)pyridine);2-(3-phenylpyrazol-1-id-5-yl)pyridine;platinum;hexakis(platinum(2+));bis(pyrazol-1-ide);pyridine-2-carboxylic acid;bis(2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine).
What is the SMILES notation for dichloroplatinum;bis(3,5-dimethylpyrazol-1-ide);5-isoquinolin-1-yl-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;bis(2-(5-methyl-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl)pyridine);bis(2-(5-methylpyrazol-2-id-3-yl)pyrazine);bis(2-(5-methylpyrazol-2-id-3-yl)pyridine);2-(3-phenylpyrazol-1-id-5-yl)pyridine;platinum;hexakis(platinum(2+));bis(pyrazol-1-ide);pyridine-2-carboxylic acid;bis(2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine)?
The canonical SMILES for dichloroplatinum;bis(3,5-dimethylpyrazol-1-ide);5-isoquinolin-1-yl-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;bis(2-(5-methyl-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl)pyridine);bis(2-(5-methylpyrazol-2-id-3-yl)pyrazine);bis(2-(5-methylpyrazol-2-id-3-yl)pyridine);2-(3-phenylpyrazol-1-id-5-yl)pyridine;platinum;hexakis(platinum(2+));bis(pyrazol-1-ide);pyridine-2-carboxylic acid;bis(2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine) is CC12CCC(c3c1n[n-]c3-c1nccc3ccccc13)C2(C)C.Cc1cc(-c2ccccn2)[n-]n1.Cc1cc(-c2ccccn2)[n-]n1.Cc1cc(-c2cnccn2)[n-]n1.Cc1cc(-c2cnccn2)[n-]n1.Cc1cc(C)[n-]n1.Cc1cc(C)[n-]n1.Cc1n[n-]c(-c2ccccn2)n1.Cc1n[n-]c(-c2ccccn2)n1.Cl[Pt]Cl.FC(F)(F)c1cc(-c2ccccn2)[n-]n1.FC(F)(F)c1cc(-c2ccccn2)[n-]n1.O=C(O)c1ccccn1.[Pt+2].[Pt+2].[Pt+2].[Pt+2].[Pt+2].[Pt+2].[Pt].c1ccc(-c2cc(-c3ccccn3)[n-]n2)cc1.c1cn[n-]c1.c1cn[n-]c1.
What is the InChIKey of dichloroplatinum;bis(3,5-dimethylpyrazol-1-ide);5-isoquinolin-1-yl-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;bis(2-(5-methyl-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl)pyridine);bis(2-(5-methylpyrazol-2-id-3-yl)pyrazine);bis(2-(5-methylpyrazol-2-id-3-yl)pyridine);2-(3-phenylpyrazol-1-id-5-yl)pyridine;platinum;hexakis(platinum(2+));bis(pyrazol-1-ide);pyridine-2-carboxylic acid;bis(2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine)?
The InChIKey is INLHRTKWDQPGNR-UHFFFAOYSA-L. The full InChI is InChI=1S/C20H20N3.C14H10N3.2C9H5F3N3.2C9H8N3.4C8H7N4.C6H5NO2.2C5H7N2.2C3H3N2.2ClH.8Pt/c1-19(2)14-8-10-20(19,3)18-15(14)17(22-23-18)16-13-7-5-4-6-12(13)9-11-21-16;1-2-6-11(7-3-1)13-10-14(17-16-13)12-8-4-5-9-15-12;2*10-9(11,12)8-5-7(14-15-8)6-3-1-2-4-13-6;2*1-7-6-9(12-11-7)8-4-2-3-5-10-8;2*1-6-4-7(12-11-6)8-5-9-2-3-10-8;2*1-6-10-8(12-11-6)7-4-2-3-5-9-7;8-6(9)5-3-1-2-4-7-5;2*1-4-3-5(2)7-6-4;2*1-2-4-5-3-1;;;;;;;;;;/h4-7,9,11,14H,8,10H2,1-3H3;1-10H;2*1-5H;2*2-6H,1H3;4*2-5H,1H3;1-4H,(H,8,9);2*3H,1-2H3;2*1-3H;2*1H;;;;;;;;/q10*-1;;4*-1;;;;7*+2/p-2.
What are the key properties of dichloroplatinum;bis(3,5-dimethylpyrazol-1-ide);5-isoquinolin-1-yl-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;bis(2-(5-methyl-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl)pyridine);bis(2-(5-methylpyrazol-2-id-3-yl)pyrazine);bis(2-(5-methylpyrazol-2-id-3-yl)pyridine);2-(3-phenylpyrazol-1-id-5-yl)pyridine;platinum;hexakis(platinum(2+));bis(pyrazol-1-ide);pyridine-2-carboxylic acid;bis(2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine)?
dichloroplatinum;bis(3,5-dimethylpyrazol-1-ide);5-isoquinolin-1-yl-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;bis(2-(5-methyl-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl)pyridine);bis(2-(5-methylpyrazol-2-id-3-yl)pyrazine);bis(2-(5-methylpyrazol-2-id-3-yl)pyridine);2-(3-phenylpyrazol-1-id-5-yl)pyridine;platinum;hexakis(platinum(2+));bis(pyrazol-1-ide);pyridine-2-carboxylic acid;bis(2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine) has a molecular weight of 3979.05 g/mol, XLogP of 21.00, 12 rotatable bonds, 1 hydrogen bond donors, and 30 hydrogen bond acceptors.
Where does this data come from?
All data for dichloroplatinum;bis(3,5-dimethylpyrazol-1-ide);5-isoquinolin-1-yl-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;bis(2-(5-methyl-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl)pyridine);bis(2-(5-methylpyrazol-2-id-3-yl)pyrazine);bis(2-(5-methylpyrazol-2-id-3-yl)pyridine);2-(3-phenylpyrazol-1-id-5-yl)pyridine;platinum;hexakis(platinum(2+));bis(pyrazol-1-ide);pyridine-2-carboxylic acid;bis(2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine) is sourced from PubChem (CID 159858727), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).